Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review

References

• YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
   PubMed Web of Science ®Google Scholar
• QuigleyHAImproving eye drop treatment for glaucoma through better adherenceOptom Vis Sci200885637437518521018
   PubMed Web of Science ®Google Scholar
• HaynesRBMcDonaldHPGargAXHelping patients follow prescribed treatment: clinical applicationsJAMA2002288222880288312472330
   PubMed Web of Science ®Google Scholar
• DiMatteoMRGiordaniPJLepperHSCroghanTWPatient adherence and medical treatment outcomes: a meta-analysisMed Care200240979481112218770
   PubMed Web of Science ®Google Scholar
• NordstromBLFriedmanDSMozaffariEQuigleyHAWalkerAMPersistence and adherence with topical glaucoma therapyAm J Ophthalmol2005140459860616226511
   PubMed Web of Science ®Google Scholar
• OlthoffCMSchoutenJSvan de BorneBWWebersCANoncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based reviewOphthalmology2005112695396115885795
   PubMed Web of Science ®Google Scholar
• LuVHGoldbergILuCYUse of glaucoma medications: state of the science and directions for observational researchAm J Ophthalmol20101504569574e56920678750
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• GranstromPAProgression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapyArch Ophthalmol198510345295313985832
   PubMedGoogle Scholar
• HahnSRKotakSTanJKimEPhysicians’ treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucomaCurr Med Res Opin201026495796320163296
   PubMed Web of Science ®Google Scholar
• GurwitzJHGlynnRJMonaneMTreatment for glaucoma: adherence by the elderlyAm J Public Health19938357117168484454
   PubMed Web of Science ®Google Scholar
• GurwitzJHYeomansSMGlynnRJLewisBELevinRAvornJPatient noncompliance in the managed care setting. The case of medical therapy for glaucomaMed Care19983633573699520960
   PubMed Web of Science ®Google Scholar
• RobinALCovertDDoes adjunctive glaucoma therapy affect adherence to the initial primary therapy?Ophthalmology2005112586386815878067
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• NorellSEImproving medication compliance: a randomised clinical trialBr Med J19792619710311033519269
   PubMed Web of Science ®Google Scholar
• NorellSMedication behaviour. A study of outpatients treated with pilocarpine eye drops for primary open-angle glaucomaActa Ophthalmol Suppl19801431286257026
   PubMedGoogle Scholar
• NorellSEGranstromPASelf-medication with pilocarpine among outpatients in a glaucoma clinicBr J Ophthalmol19806421371417362816
   PubMed Web of Science ®Google Scholar
• NorellSEMonitoring compliance with pilocarpine therapyAm J Ophthalmol19819257277317304700
   PubMed Web of Science ®Google Scholar
• NorellSEAccuracy of patient interviews and estimates by clinical staff in determining medication complianceSoc Sci Med E198115157617271967
   PubMedGoogle Scholar
• GranstromPAGlaucoma patients not compliant with their drug therapy: clinical and behavioural aspectsBr J Ophthalmol19826674644707093186
   PubMed Web of Science ®Google Scholar
• GranstromPANorellSVisual ability and drug regimen: relation to compliance with glaucoma therapyActa Ophthalmol (Copenh)19836122062196880634
   PubMed Web of Science ®Google Scholar
• KassMAMeltzerDWGordonMCooperDGoldbergJCompliance with topical pilocarpine treatmentAm J Ophthalmol198610155155233706455
   PubMed Web of Science ®Google Scholar
• KassMAGordonMMeltzerDWCan ophthalmologists correctly identify patients defaulting from pilocarpine therapy?Am J Ophthalmol198610155245303706456
   PubMed Web of Science ®Google Scholar
• KassMAGordonMMorleyREJrMeltzerDWGoldbergJJCompliance with topical timolol treatmentAm J Ophthalmol198710321881933812621
   PubMed Web of Science ®Google Scholar
• RobinALNovackGDCovertDWCrockettRSMarcicTSAdherence in glaucoma: objective measurements of once-daily and adjunctive medication useAm J Ophthalmol2007144453354017686450
   PubMed Web of Science ®Google Scholar
• HermannMMPapaconstantinouDMuetherPSGeorgopoulosGDiestelhorstMAdherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoringActa Ophthalmol2011894e300e30521106046
   PubMed Web of Science ®Google Scholar
• HermannMMBronAMCreuzot-GarcherCPDiestelhorstMMeasurement of adherence to brimonidine therapy for glaucoma using electronic monitoringJ Glaucoma2010 [Epub ahead of print]
   Web of Science ®Google Scholar
• SchwartzGFPlattRReardonGMychaskiwMAAccounting for restart rates in evaluating persistence with ocular hypotensivesOphthalmology2007114464865217398318
   PubMed Web of Science ®Google Scholar
• ZimmermanTJHahnSRGelbLTanHKimEEThe impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistenceJ Ocul Pharmacol Ther200925214515219284321
   PubMed Web of Science ®Google Scholar
• BhosleMJReardonGCamachoFTAndersonRTBalkrishnanRMedication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care populationAm J Geriatr Pharmacother20075210011117719512
   PubMedGoogle Scholar
• DasguptaSOatesVBookhartBKVaziriBSchwartzGFMozaffariEPopulation-based persistency rates for topical glaucoma medications measured with pharmacy claims dataAm J Manag Care20028Suppl 10S25526112188168
   PubMed Web of Science ®Google Scholar
• JayawantSSBhosleMJAndersonRTBalkrishnanRDepressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucomaJ Glaucoma200716651352017873711
   PubMed Web of Science ®Google Scholar
• OwenCGCareyIMde WildeSWhincupPHWormaldRCookDGPersistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994–2005Eye (Lond)20092351098111018617908
   PubMed Web of Science ®Google Scholar
• RaitJLAdenaMAPersistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims dataClin Experiment Ophthalmol200735760261117894679
   PubMed Web of Science ®Google Scholar
• ReardonGSchwartzGFMozaffariEPatient persistency with ocular prostaglandin therapy: a population-based, retrospective studyClin Ther20032541172118512809964
   PubMed Web of Science ®Google Scholar
• ReardonGSchwartzGFMozaffariEPatient persistency with pharmacotherapy in the management of glaucomaEur J Ophthalmol200313Suppl 4S445212948052
   PubMed Web of Science ®Google Scholar
• SchwartzGFReardonGMozaffariEPersistency with latanoprost or timolol in primary open-angle glaucoma suspectsAm J Ophthalmol2004137Suppl 1S131614697910
   PubMed Web of Science ®Google Scholar
• ShayaFTMullinsCDWongWChoJDiscontinuation rates of topical glaucoma medications in a managed care populationAm J Manag Care20028Suppl 10S27127712188170
   PubMed Web of Science ®Google Scholar
• SpoonerJJBullanoMFIkedaLIRates of discontinuation and change of glaucoma therapy in a managed care settingAm J Manag Care20028Suppl 10S26227012188169
   PubMed Web of Science ®Google Scholar
• ReardonGSchwartzGFMozaffariEPatient persistency with topical ocular hypotensive therapy in a managed care populationAm J Ophthalmol2004137Suppl 1S31214697909
   PubMed Web of Science ®Google Scholar
• De NataleRLafumaABerdeauxGCost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research databaseClin Drug Investig2009292111120
   Web of Science ®Google Scholar
• DenisPLafumaABerdeauxGCosts and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research DatabaseClin Ophthalmol20082232132919668723
   PubMedGoogle Scholar
• LafumaABerdeauxGCosts and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research DatabaseCurr Med Res Opin200723123009301617958945
   PubMed Web of Science ®Google Scholar
• LafumaABerdeauxGCosts and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD databaseCurr Med Res Opin20082451519152718413015
   PubMed Web of Science ®Google Scholar
• LafumaALaurendeauCBerdeauxGCosts and persistence of brimonidine versus brinzolamide in everyday glaucoma care: an analysis conducted on the UK General Practitioner Research DatabaseJ Med Econ200811348549719450100
   PubMedGoogle Scholar
• ZhouZAlthinRSforzoliniBSDhawanRPersistency and treatment failure in newly diagnosed open angle glaucoma patients in the United KingdomBr J Ophthalmol200488111391139415489479
   PubMed Web of Science ®Google Scholar
• FriedmanDSQuigleyHAGelbLUsing pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)Invest Ophthalmol Vis Sci200748115052505717962457
   PubMed Web of Science ®Google Scholar
• ReardonGSchwartzGFKotakSPersistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapyBMC Ophthalmol201010520196848
   PubMed Web of Science ®Google Scholar
• WilenskyJFiscellaRGCarlsonAMMorrisLSWaltJMeasurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims dataAm J Ophthalmol2006141Suppl 1S283316389058
   PubMed Web of Science ®Google Scholar
• TraversoCEWaltJGSternLSDolgitserMPharmacotherapy compliance in patients with ocular hypertension or primary open-angle glaucomaJ Ocul Pharmacol Ther2009251778219232009
   PubMed Web of Science ®Google Scholar
• DjafariFLeskMRHarasymowyczPJDesjardinsDLachaineJDeterminants of adherence to glaucoma medical therapy in a long-term patient populationJ Glaucoma200918323824319295380
   PubMed Web of Science ®Google Scholar
• LeePPWaltJGChiangTHGuckianAKeenerJA gap analysis approach to assess patient persistence with glaucoma medicationAm J Ophthalmol2007144452052417692273
   PubMed Web of Science ®Google Scholar
• FriedmanDSHahnSRGelbLDoctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency StudyOphthalmology20081158132013271327.e1e318321582
   PubMed Web of Science ®Google Scholar
• HigginbothamEJHansenJDavisEJWaltJGGuckianAGlaucoma medication persistence with a fixed combination versus multiple bottlesCurr Med Res Opin200925102543254719731993
   PubMed Web of Science ®Google Scholar
• MuirKWSantiago-TurlaCStinnettSSHealth literacy and adherence to glaucoma therapyAm J Ophthalmol2006142222322616876500
   PubMed Web of Science ®Google Scholar
• MuirKWSantiago-TurlaCStinnettSSGlaucoma patients’ trust in the physicianJ Ophthalmol2009200947672620339452
   PubMed Web of Science ®Google Scholar
• RotchfordAPMurphyKMCompliance with timolol treatment in glaucomaEye (Lond)199812Pt 22342369683946
   PubMed Web of Science ®Google Scholar
• StrykerJEBeckADPrimoSAAn exploratory study of factors influencing glaucoma treatment adherenceJ Glaucoma2010191667220075676
   PubMed Web of Science ®Google Scholar
• YousufSJJonesLSAdherence to topical glaucoma medication during hospitalizationJ Glaucoma2010 [Epub ahead of print]
   Web of Science ®Google Scholar
• AriasASchargelKUssaFCanutMIRoblesAYSanchezBMPatient persistence with first-line antiglaucomatous monotherapyClin Ophthalmol2010426126720463793
   PubMedGoogle Scholar
• DayDGSchacknowPNSharpeEDA persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertensionJ Ocul Pharmacol Ther200420538339215650513
   PubMed Web of Science ®Google Scholar
• DiestelhorstMSchaeferCPBeusterienKMPersistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort studyEur J Ophthalmol200313Suppl 4S212912948050
   PubMed Web of Science ®Google Scholar
• TingeyDBernardLMGrimaDTMillerBLamAIntraocular pressure control and persistence on treatment in glaucoma and ocular hypertensionCan J Ophthalmol200540216116916049529
   PubMed Web of Science ®Google Scholar
• KashiwagiKChanges in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local communityOpen Ophthalmol J2010471120556196
   PubMedGoogle Scholar
• QuigleyHAFriedmanDSHahnSREvaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency StudyOphthalmology200711491599160617572498
   PubMed Web of Science ®Google Scholar
• SleathBRobinALCovertDByrdJETudorGSvarstadBPatientreported behavior and problems in using glaucoma medicationsOphthalmology2006113343143616458967
   PubMed Web of Science ®Google Scholar
• StoneJLRobinALNovackGDCovertDWCagleGDAn objective evaluation of eyedrop instillation in patients with glaucomaArch Ophthalmol2009127673273619506189
   PubMedGoogle Scholar
• GrayTAOrtonLCHensonDHarperRWatermanHInterventions for improving adherence to ocular hypotensive therapyCochrane Database Syst Rev20092CD00613219370627
   PubMed Web of Science ®Google Scholar
• KahookMYDevelopments in dosing aids and adherence devices for glaucoma therapy: current and future perspectivesExpert Rev Med Devices20074226126617359230
   PubMed Web of Science ®Google Scholar